Bio Green Med Solution (BGMS) Other Non Operating Income (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Other Non Operating Income of $39000.0 for Q1 2026, up 290.0% year-over-year from $10000.0 in Q1 2025, and down 88.29% quarter-over-quarter from $333000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Other Non Operating Income (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Other Non Operating Income for 17 consecutive years, with $39000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income rose 290.0% year-over-year to $39000.0; the TTM figure through Mar 2026 stood at $355000.0 (up 129.71% YoY), while the FY2025 annual figure was $354000.0, up 130.57% from the prior year.
- Other Non Operating Income retreated to $39000.0 in Q1 2026 per BGMS's latest filing, from $333000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $784000.0 in Q4 2022 and bottomed at -$1.2 million in Q4 2024.
- Historically, Other Non Operating Income has averaged -$1588.2 across 5 years, with a median of $10000.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Non Operating Income jumped 1707.69% — and 2025, when it tumbled 800.0%.
- Bio Green Med Solution's Other Non Operating Income stood at $784000.0 in 2022, then sank by 145.41% to -$356000.0 in 2023, then plunged by 239.89% to -$1.2 million in 2024, then surged by 127.52% to $333000.0 in 2025, then sank by 88.29% to $39000.0 in 2026.
- Business Quant data shows BGMS's Other Non Operating Income at $39000.0 in Q1 2026, $333000.0 in Q4 2025, and -$14000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31,000.00 |
| Mar 31, 2026 | 39,000.00 |
| Sep 30, 2025 | -14,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | -1.21 Mn |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | -356,000.00 |
| Sep 30, 2023 | 104,000.00 |
| Jun 30, 2023 | -106,000.00 |
| Mar 31, 2023 | 166,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | 276,000.00 |
| Jun 30, 2022 | 209,000.00 |
| Mar 31, 2022 | 1.28 Mn |
| Sep 30, 2021 | 9,000.00 |
| Jun 30, 2021 | 18,000.00 |
| Mar 31, 2021 | 126,000.00 |